Stock listing
Acrivon Therapeutics, Inc.
Selected listing: ACRV · NASDAQ · USD · US
Acrivon Therapeutics, Inc. (NASDAQ:ACRV), Health Technology. Latest release Sep 2, 2026: Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare…
- Ticker
- NASDAQ:ACRV
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. is a public company traded under the ticker ACRV in the American market. Acrivon focuses on advancing its therapeutic innovations to improve patient outcomes.
Latest news from Acrivon Therapeutics, Inc.
Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference
September 2, 2026
Acrivon Therapeutics Appoints Michaela Levin, Ph.D., as Chief Business Officer
August 31, 2026
Acrivon Reports Second Quarter 2026 Financial Results and Highlights Upcoming 2026 Clinical Data Catalysts
August 12, 2026
Acrivon Advances ACR-2316, a Potential First-in-Class WEE1/PKMYT1 Inhibitor, into Randomized Dose Expansion in its Ongoing Phase 1/2 Study
August 5, 2026
Acrivon to Highlight the Power of its AP3 Platform for Streamlined, Pathway-Based Drug Discovery and Development with Oral and Poster Presentations at AACR D3 Conference
July 21, 2026
Research Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. company profile
View the public company page for Acrivon Therapeutics, Inc. on 6ix.
Acrivon Therapeutics, Inc. news
Read company news and market updates connected to Acrivon Therapeutics, Inc..
Acrivon Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Acrivon Therapeutics, Inc..